Fresenius Medical Care Ag ADR
(FMS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,442,232 | 1,079,306 | 703,724 | 366,905 | 1,640,151 |
| Depreciation Amortization | 1,920,971 | 1,399,201 | 944,322 | 468,016 | 2,040,032 |
| Income taxes - deferred | 79,574 | -15,127 | -44,357 | -7,299 | 126,914 |
| Accounts receivable | -193,078 | -105,985 | -251,288 | -579,320 | 81,897 |
| Accounts payable and accrued liabilities | 23,302 | -6,769 | 4,749 | 7,519 | -18,632 |
| Other Working Capital | -115,669 | 42,027 | 2,381 | -469,047 | 1,411,269 |
| Other Operating Activity | -212,007 | -245,977 | 524 | 463,565 | -446,097 |
| Operating Cash Flow | $2,945,325 | $2,146,676 | $1,360,055 | $250,340 | $4,835,534 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -981,897 | -661,807 | -458,072 | -215,712 | -1,183,885 |
| Net Acquisitions | -451,621 | -316,043 | -152,813 | -126,164 | -279,152 |
| Purchase Of Investment | -152,716 | -73,865 | -75,086 | -12,947 | -110,119 |
| Sale Of Investment | 170,977 | 139,677 | 115,838 | 84,704 | 48,252 |
| Investing Cash Flow | $-1,415,257 | $-912,038 | $-570,132 | $-270,118 | $-1,524,904 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,134,557 | 2,088,988 | 2,012,800 | 1,290,632 | 907,931 |
| Debt Issued | 1,471,888 | 1,452,487 | 1,482,155 | 11,686 | 2,422,710 |
| Debt Repayment | -2,464,397 | -2,437,675 | -2,461,354 | -1,070,832 | -1,811,937 |
| Common Stock Issued | 7,703 | 7,081 | 6,299 | 693 | 14,454 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -418,068 |
| Dividend Paid | -860,468 | -757,801 | -664,787 | -83,817 | -819,540 |
| Other Financing Activity | -1,501,230 | -1,139,428 | -830,950 | -191,661 | -3,338,668 |
| Financing Cash Flow | $-1,211,946 | $-786,348 | $-455,837 | $-43,299 | $-3,043,118 |
| Exchange Rate Effect | 155,256 | 118,075 | 59,216 | 53,359 | -183,192 |
| Beginning Cash Position | 1,279,569 | 1,275,351 | 1,303,146 | 1,303,903 | 1,151,122 |
| End Cash Position | 1,752,946 | 1,841,715 | 1,696,449 | 1,294,185 | 1,235,442 |
| Net Cash Flow | $473,377 | $566,364 | $393,302 | $-9,718 | $84,320 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,945,325 | 2,146,676 | 1,360,055 | 250,340 | 4,835,534 |
| Capital Expenditure | -1,010,793 | -693,603 | -474,319 | -222,193 | -1,201,680 |
| Free Cash Flow | 1,934,532 | 1,453,073 | 885,737 | 28,147 | 3,633,854 |